622381-67-3

Usage

Uses

Used in Pharmaceutical Industry:
TERT-BUTYL 4-[4-(HYDROXYMETHYL)BENZYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is used as a building block for the synthesis of various bioactive compounds. Its unique structure and properties make it a valuable component in the development of drug molecules, particularly in medicinal chemistry.
Used in Flavoring Agents for Food Products:
Due to its aromatic properties, TERT-BUTYL 4-[4-(HYDROXYMETHYL)BENZYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is also used as a flavoring agent in the food industry. Its ability to impart a distinct flavor profile to food products makes it a sought-after ingredient in the development of new and innovative food items.

InChI:InChI=1/C17H26N2O3/c1-17(2,3)22-16(21)19-10-8-18(9-11-19)12-14-4-6-15(13-20)7-5-14/h4-7,20H,8-13H2,1-3H3

Upstream product

• 1571-08-0 methyl 4-formylbenzoate 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 52010-97-6 4-(hydroxylmethyl)benzaldehyde 
• 844891-11-8 tert-butyl 4-[(4-methoxycarbonylphenyl)methyl]piperazine-1-carboxylate 

Relevant academic research and scientific papers

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same. The compounds include an IRAK binding moiety and a degradation inducing moiety (DIM). The DIM could be DTM a ligase binding moiety (LBM) or lysine mimetic. The compounds could be useful as IRAK protein kinase inhibitors and applied to IRAK mediated disorders.

CONJUGATE COMPOUNDS FOR THE DEGRADATION OF RAF

The present disclosure provides, inter alia, RAF-Degrading Conjugate Compounds that are useful in the treatment of cancer and other RAF related diseases. Also provided are, pharmaceutical compositions, methods of treatment, and kits comprising a RAF-Degrading Conjugate Compound.

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

PIPERAZINE BENZOTHIAZOLES AS AGENTS FOR THE TREATMENT OF CEREBRAL ISCHEMIC DISORDERS OR CNS DISORDERS

The present invention is related to piperazine benzothiazole derivatives, notably for use in the treatment and/or prophylaxis of cerebral ischemic disorders or CNS disorders. The present invention is furthermore related to methods of their preparation.